Literature DB >> 24178438

Homologous SV40 RNA trans-splicing: a new mechanism for diversification of viral sequences and phenotypes.

Joachim Eul1, Volker Patzel2.   

Abstract

Simian Virus 40 (SV40) is a polyomavirus found in both monkeys and humans, which causes cancer in some animal models. In humans, SV40 has been reported to be associated with cancers but causality has not been proven yet. The transforming activity of SV40 is mainly due to its 94-kD large T antigen, which binds to the retinoblastoma (pRb) and p53 tumor suppressor proteins, and thereby perturbs their functions. Here we describe a 100 kD super T antigen harboring a duplication of the pRB binding domain that was associated with unusual high cell transformation activity and that was generated by a novel mechanism involving homologous RNA trans-splicing of SV40 early transcripts in transformed rodent cells. Enhanced trans-splice activity was observed in clones carrying a single point mutation in the large T antigen 5' donor splice site (ss). This mutation impaired cis-splicing in favor of an alternative trans-splice reaction via a cryptic 5'ss within a second cis-spliced SV40 pre-mRNA molecule and enabled detectable gene expression. Next to the cryptic 5'ss we identified additional trans-splice helper functions, including putative dimerization domains and a splice enhancer sequence. Our findings suggest RNA trans-splicing as a SV40-intrinsic mechanism that supports the diversification of viral RNA and phenotypes.

Entities:  

Keywords:  SV40 100 kD super T antigen; alternative splicing; cell transformation; molecular basis of diseases; trans-splicing; viral gene expression

Mesh:

Substances:

Year:  2013        PMID: 24178438      PMCID: PMC3907479          DOI: 10.4161/rna.26707

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  62 in total

1.  Heterologous HIV-nef mRNA trans-splicing: a new principle how mammalian cells generate hybrid mRNA and protein molecules.

Authors:  C Caudevilla; L Da Silva-Azevedo; B Berg; E Guhl; M Graessmann; A Graessmann
Journal:  FEBS Lett       Date:  2001-11-02       Impact factor: 4.124

2.  Natural trans-spliced mRNAs are generated from the human estrogen receptor-alpha (hER alpha) gene.

Authors:  Gilles Flouriot; Heike Brand; Bertrand Seraphin; Frank Gannon
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

3.  The trans-spliced variants of Sp1 mRNA in rat.

Authors:  Terunao Takahara; Daisuke Kasahara; Daisuke Mori; Shuichi Yanagisawa; Hiroshi Akanuma
Journal:  Biochem Biophys Res Commun       Date:  2002-10-18       Impact factor: 3.575

4.  Naturally occurring heterologous trans-splicing of adenovirus RNA with host cellular transcripts during infection.

Authors:  Toyone Kikumori; Gilbert J Cote; Robert F Gagel
Journal:  FEBS Lett       Date:  2002-07-03       Impact factor: 4.124

5.  Promoter choice determines splice site selection in protocadherin alpha and gamma pre-mRNA splicing.

Authors:  Bosiljka Tasic; Christoph E Nabholz; Kristin K Baldwin; Youngwook Kim; Erroll H Rueckert; Scott A Ribich; Paula Cramer; Qiang Wu; Richard Axel; Tom Maniatis
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

6.  In vitro selection supports the view of a kinetic control of antisense RNA-mediated inhibition of gene expression in mammalian cells.

Authors:  V Patzel; G Sczakiel
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

7.  Intergenic mRNA molecules resulting from trans-splicing.

Authors:  Csaba Finta; Peter G Zaphiropoulos
Journal:  J Biol Chem       Date:  2001-11-28       Impact factor: 5.157

8.  Localization of an exonic splicing enhancer responsible for mammalian natural trans-splicing.

Authors:  C Caudevilla; C Codony; D Serra; G Plasencia; R Román; A Graessmann; G Asins; M Bach-Elias; F G Hegardt
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

Review 9.  SV40 and human tumours: myth, association or causality?

Authors:  Adi F Gazdar; Janet S Butel; Michele Carbone
Journal:  Nat Rev Cancer       Date:  2002-12       Impact factor: 60.716

10.  Trans-splicing and alternative-tandem-cis-splicing: two ways by which mammalian cells generate a truncated SV40 T-antigen.

Authors:  J Eul; M Graessmann; A Graessmann
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

View more
  5 in total

Review 1.  Expression of novel proteins by polyomaviruses and recent advances in the structural and functional features of agnoprotein of JC virus, BK virus, and simian virus 40.

Authors:  A Sami Saribas; Pascale Coric; Serge Bouaziz; Mahmut Safak
Journal:  J Cell Physiol       Date:  2018-11-02       Impact factor: 6.384

2.  Discovery and characterization of novel trans-spliced products of human polyoma JC virus late transcripts from PML patients.

Authors:  A Sami Saribas; Julia DeVoto; Akhil Golla; Hassen S Wollebo; Martyn K White; Mahmut Safak
Journal:  J Cell Physiol       Date:  2017-12-18       Impact factor: 6.384

3.  RNA Structure Design Improves Activity and Specificity of trans-Splicing-Triggered Cell Death in a Suicide Gene Therapy Approach.

Authors:  Sushmita Poddar; Pei She Loh; Zi Hao Ooi; Farhana Osman; Joachim Eul; Volker Patzel
Journal:  Mol Ther Nucleic Acids       Date:  2018-01-31       Impact factor: 8.886

4.  Long-read sequencing reveals complex patterns of wraparound transcription in polyomaviruses.

Authors:  Jason Nomburg; Wei Zou; Thomas C Frost; Chandreyee Datta; Shobha Vasudevan; Gabriel J Starrett; Michael J Imperiale; Matthew Meyerson; James A DeCaprio
Journal:  PLoS Pathog       Date:  2022-04-01       Impact factor: 7.464

5.  Homologous SV40 RNA trans-splicing: Special case or prime example of viral RNA trans-splicing?

Authors:  Sushmita Poddar; Joachim Eul; Volker Patzel
Journal:  Comput Struct Biotechnol J       Date:  2014-07-08       Impact factor: 7.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.